Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

PI3K

Items 1-10 of 66

Page
per page
  1. GO-203 TFA
    C9120 GO-203 TFA
    Summary: A cell-permeable all-D peptide research tool that selectively targets MUC1-C, for research use.
  2. Pilaralisib
    C9087 Pilaralisib
    Summary: A reversible, selective class I PI3K inhibitor with preference for p110α/δ/γ, for research use.
  3. Voxtalisib
    C9073 Voxtalisib
    Summary: A small-molecule PI3K/mTOR dual inhibitor for in vitro signal transduction research.
  4. Eganelisib
    C9059 Eganelisib
    Summary: A highly selective PI3Kγ inhibitor for signal transduction and macrophage research in scientific studies.
  5. Quercetin
    N1841 Quercetin
     9 Citation
    Summary: Antitumor agent
      insoluble in H2O; ≥15.1 mg/mL
  6. GSK2269557
    C5012 GSK2269557
    Summary: inhibitor of PI3Kδ
      ≤0.2 mg/mL
  7. AS-041164
    C4243 AS-041164
    Summary: PI3Kγ inhibitor
      ≤25 mg/mL
  8. PX 866
    C3271 PX 866
    Summary: PI3K inhibitor
      ≤25 mg/mL
  9. INK1117
    C3103 INK1117
    Summary: PI3Kα inhibitor
      ≤1 mg/mL
  10. GDC-0084
    B7826 GDC-0084
    Summary: PI3K and mTOR inhibitor, brain-permeable
      insoluble in H2O; insoluble in EtOH; ≥2.83 mg/mL

Items 1-10 of 66

Page
per page